Funder: Health Resources in Action
Due Dates (Anticipated): October 2027 (Initial Stage Application)
Funding Amounts: Postdoctoral Fellowship: up to $125,000 over two years | Early Career Investigator: up to $275,000 over two years
Summary: Supports preclinical and translational Alzheimer’s drug discovery, especially research benefiting highly burdened or historically understudied populations.
Key Information: Applicants must work at eligible U.S. nonprofit institutions; government-employed scientists are ineligible.
Description
The Edward N. & Della L. Thome Memorial Foundation supports innovative preclinical and translational drug discovery research to improve therapies for people with Alzheimer’s disease. Health Resources in Action (HRiA) administers the program with a Scientific Review Committee. Postdoctoral fellowships and early-career investigator awards support researchers advancing biological insights toward clinically relevant treatments.
The program prioritizes populations experiencing high disease burden or historical underrepresentation in research. Potential topics include reproductive biology and hormones, X inactivation, genetic variation across ancestries, representative biospecimen cohorts, and environmental or lifestyle influences on disease and treatment response. Eligible approaches include cell and animal models, tissue samples, computer-assisted simulations, and human disease studies linked to model-system findings. Researchers from fields outside Alzheimer’s disease are encouraged to apply.
